A model for NICE in the US

BMJ (Online)

Volumn 338, Issue 7708, 2009, Pages 1401-

  Ferner, R E ^a   McDowell, Sarah E ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; PEMETREXED;

CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DRUG COST; EDITORIAL; FUNDING; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH INSURANCE; HEALTH SERVICE; HUMAN; LIFE EXPECTANCY; PATIENT RIGHT; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; TOTAL QUALITY MANAGEMENT; UNITED STATES;

COST-BENEFIT ANALYSIS; HEALTH EXPENDITURES; HEALTH SERVICES; QUALITY-ADJUSTED LIFE YEARS; TECHNOLOGY ASSESSMENT, BIOMEDICAL; UNITED STATES;

EID: 67650070323     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b2221     Document Type: Editorial

References (12)

1. Avorn J. Debate about funding comparative-effectiveness research. N Engl J Med 2009;360:1927-9.[Free Full Text]
2. McGreal C. In the US, things are getting nasty over NICE. BMJ 2009;338:1241.
3. World Health Organization. World health statistics 2008. Geneva: WHO Press, 2008.
4. Marmot MG, Bell R. Action on health disparities in the United States: commission on social determinants of health. JAMA 2009;30:1169-71.
5. DeNavas-Walt C, Proctor BD, Smith JC. Current population reports. P60-235: Income, poverty, and health insurance coverage in the United States: 2007. Washington, DC: US Government Printing Office, 2008.
6. Solomon MD, Goldman DP, Joyce GF, Escarce JJ. Cost sharing and the initiation of drug therapy for the chronically ill. Arch Intern Med 2009;169:740-8.[Abstract/Free Full Text]
7. Hardin G. The tragedy of the commons. Science 1968;162:1243-8. [Abstract/Free Full Text]
8. Ferner RE, McDowell SE. How NICE may be outflanked. BMJ 2006;332;1268-71.
9. Walker S, Palmer S, Sculpher M. The role of NICE technology appraisal in NHS rationing. Br Med Bull 2007;81-82:54-64.
10. Pearson SD, Rawlins MD. Quality, innovation, and value for money: NICE and the British National Health Service. JAMA 2005;294:2618-22.[Abstract/ Free Full Text]
11. Wilson PM, Booth AM, Eastwood A, Watt IS. Deconstructing media coverage of trastuzumab (Herceptin): an analysis of national newspaper coverage. J R Soc Med 2008;101:125-32. [Abstract/Free Full Text]
12. Rosenthal MB. What works in market-oriented health policy? N Engl J Med 2009;360:2157-60.[Free Full Text]